RT @notthewongrx: Check out our work (@DBatesSafety, with support from @accpcritprn) on med CDS high dose-range overrides in the ICU, now i…
RT @notthewongrx: Check out our work (@DBatesSafety, with support from @accpcritprn) on med CDS high dose-range overrides in the ICU, now i…
RT @notthewongrx: Check out our work (@DBatesSafety, with support from @accpcritprn) on med CDS high dose-range overrides in the ICU, now i…
Check out our work (@DBatesSafety, with support from @accpcritprn) on med CDS high dose-range overrides in the ICU, now in-print @DrugSafetyJ. Approx 90% appro overridden, with ADEs rare. Still a lot of work that needs to be done to improve CDS! https://t.
Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit. https://t.co/l0cgThdk6h
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
RT @DBatesSafety: Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were…
Check out our Drug Safety paper on harm associated with high dose-range overrides in the ICU--very large proportion were clinically appropriate, implication is that the decision support needs to be cleaned up. https://t.co/O5E2Yk5tXw